InMode (INMD) Return on Capital Employed (2019 - 2026)
InMode recorded quarterly Return on Capital Employed of 11.72% in Q1 2026, down 6.72% quarter-over-quarter from 12.56% in Q4 2025, and down 465.0% year-over-year from 3.21% in Q1 2025.
InMode's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 11.72% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 465.0% year-over-year to 11.72%; the TTM figure through Mar 2026 stood at 11.72% (down 465.0% YoY), while the FY2025 annual figure was 12.11%, down 281.0% from the prior year.
- Return on Capital Employed came in at 11.72% for Q1 2026 at InMode, down from 12.56% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 42.07% in Q2 2022 to a low of 11.72% in Q1 2026.
- A 5-year average of 25.23% and a median of 22.06% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed jumped 695 bps in 2022 and tumbled 1680 bps in 2024, its largest moves.
- InMode's Return on Capital Employed stood at 37.35% in 2022, then decreased by 29 bps to 26.45% in 2023, then plunged by 42 bps to 15.31% in 2024, then retreated by 18 bps to 12.56% in 2025, then retreated by 7 bps to 11.72% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 11.72%, 12.56%, and 13.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | 11.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.72% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 13.36% |
| Jun 30, 2025 | 17.91% |
| Mar 31, 2025 | 16.36% |
| Dec 31, 2024 | 15.31% |
| Sep 30, 2024 | 17.74% |
| Jun 30, 2024 | 17.23% |
| Mar 31, 2024 | 22.06% |
| Dec 31, 2023 | 26.45% |
| Sep 30, 2023 | 30.05% |
| Jun 30, 2023 | 34.03% |
| Mar 31, 2023 | 34.13% |
| Dec 31, 2022 | 37.35% |
| Sep 30, 2022 | 38.95% |
| Jun 30, 2022 | 42.07% |
| Mar 31, 2022 | 41.67% |
| Dec 31, 2021 | 40.72% |
| Sep 30, 2021 | 41.16% |
| Jun 30, 2021 | 40.71% |
| Mar 31, 2021 | 34.72% |
| Dec 31, 2020 | 32.99% |
| Sep 30, 2020 | 29.90% |
| Jun 30, 2020 | 27.19% |
| Mar 31, 2020 | 32.29% |
| Dec 31, 2019 | 35.42% |
| Sep 30, 2019 | 35.73% |